{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:11:24Z","timestamp":1778692284350,"version":"3.51.4"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T00:00:00Z","timestamp":1655337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["737043"],"award-info":[{"award-number":["737043"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Drugs are often withdrawn from the market due to the manifestation of drug-induced liver injury (DILI) in patients. Drug-induced cholestasis (DIC), defined as obstruction of hepatic bile flow due to medication, is one form of DILI. Because DILI is idiosyncratic, and the resulting cholestasis complex, there is no suitable in vitro model for early DIC detection during drug development. Our goal was to develop a mouse precision-cut liver slice (mPCLS) model to study DIC and to assess cholestasis development using conventional molecular biology and analytical chemistry methods. Cholestasis was induced in mPCLS through a 48-h-incubation with three drugs known to induce cholestasis in humans, namely chlorpromazine (15, 20, and 30\u00a0\u00b5M), cyclosporin A (1, 3, and 6 \u00b5M) or glibenclamide (25, 50, and 65\u00a0\u00b5M). A bile-acid mixture (16\u00a0\u00b5M) that is physiologically representative of the human bile-acid pool was added to the incubation medium with drug, and results were compared to incubations with no added bile acids. Treatment of PCLS with cholestatic drugs increased the intracellular bile-acid concentration of deoxycholic acid and modulated bile-transporter genes. Chlorpromazine led to the most pronounced cholestasis in 48\u00a0h, observed as increased toxicity; decreased protein and gene expression of the bile salt export pump; increased gene expression of multidrug resistance-associated protein 4; and accumulation of intracellular bile acids. Moreover, chlorpromazine-induced cholestasis exhibited some transition into fibrosis, evidenced by increased gene expression of collagen 1A1 and heatshock protein 47. In conclusion, we demonstrate that mPCLS can be used to study human DIC onset and progression in a 48\u00a0h period. We thus propose this model is suited for other similar studies of human DIC.<\/jats:p>","DOI":"10.1007\/s00204-022-03321-2","type":"journal-article","created":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T11:03:09Z","timestamp":1655377389000},"page":"2523-2543","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Mouse precision-cut liver slices as an ex vivo model to study drug-induced cholestasis"],"prefix":"10.1007","volume":"96","author":[{"given":"R. E. H.","family":"Karsten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N. J. W.","family":"Krijnen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Maho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Permentier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Verpoorte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4855-8452","authenticated-orcid":false,"given":"P.","family":"Olinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"key":"3321_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.jchromb.2008.08.018","volume":"873","author":"Y Alnouti","year":"2008","unstructured":"Alnouti Y, Csanaky IL, Klaassen CD (2008) Quantitative-profiling of bile acids and their conjugates in mouse liver, bile, plasma, and urine using LC-MS\/MS. J Chromatogr B Analyt Technol Biomed Life Sci 873:209\u2013217. https:\/\/doi.org\/10.1016\/j.jchromb.2008.08.018","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"3321_CR2","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1002\/hep.26160","volume":"57","author":"S Anth\u00e9rieu","year":"2013","unstructured":"Anth\u00e9rieu S, Azzi PB-E, Dumont J, Abdel-Razzak Z, Guguen-Guillouzo C, Fromenty B, Robin M-A, Guillouzo A (2013) Oxidative stress plays a major role in chlorpromazine-induced cholestasis in human HepaRG cells. Hepatology 57:1518\u20131529. https:\/\/doi.org\/10.1002\/hep.26160","journal-title":"Hepatology"},{"key":"3321_CR3","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.etp.2005.10.006","volume":"57","author":"A Barth","year":"2006","unstructured":"Barth A, Braun J, M\u00fcller D (2006) Bile acid transport and metabolism in rat liver slices. Exp Toxicol Pathol 57:313\u2013319. https:\/\/doi.org\/10.1016\/j.etp.2005.10.006","journal-title":"Exp Toxicol Pathol"},{"key":"3321_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/s0378-4274(99)00113-7","volume":"108","author":"H Bernstein","year":"1999","unstructured":"Bernstein H, Payne CM, Bernstein C, Schneider J, Beard SE, Crowley CL (1999) Activation of the promoters of genes associated with DNA damage, oxidative stress, ER stress and protein malfolding by the bile salt, deoxycholate. Toxicol Lett 108:37\u201346. https:\/\/doi.org\/10.1016\/s0378-4274(99)00113-7","journal-title":"Toxicol Lett"},{"key":"3321_CR5","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1080\/00498250400008363","volume":"34","author":"J Borlak","year":"2004","unstructured":"Borlak J, Klutcka T (2004) Expression of basolateral and canalicular transporters in rat liver and cultures of primary hepatocytes. Xenobiotica 34:935\u2013947. https:\/\/doi.org\/10.1080\/00498250400008363","journal-title":"Xenobiotica"},{"key":"3321_CR6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.taap.2013.10.032","volume":"274","author":"S Chatterjee","year":"2014","unstructured":"Chatterjee S, Richert L, Augustijns P, Annaert P (2014) Hepatocyte-based in vitro model for assessment of drug-induced cholestasis. Toxicol Appl Pharmacol 274:124\u2013136. https:\/\/doi.org\/10.1016\/j.taap.2013.10.032","journal-title":"Toxicol Appl Pharmacol"},{"key":"3321_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.cbi.2015.11.029","volume":"255","author":"Y Cheng","year":"2016","unstructured":"Cheng Y, Woolf TF, Gan J, He K (2016) In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: a review. Chem Biol Interact 255:23\u201330. https:\/\/doi.org\/10.1016\/j.cbi.2015.11.029","journal-title":"Chem Biol Interact"},{"key":"3321_CR8","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1161\/01.ATV.0000178994.21828.a7","volume":"25","author":"T Claudel","year":"2005","unstructured":"Claudel T, Staels B, Kuipers F (2005) The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. Arterioscler Thromb Vasc Biol 25:2020\u20132030. https:\/\/doi.org\/10.1161\/01.ATV.0000178994.21828.a7","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"3321_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1756-8722-4-41","volume":"4","author":"J Dai","year":"2011","unstructured":"Dai J, Wang H, Shi Y, Dong Y, Zhang Y, Wang J (2011) Impact of bile acids on the growth of human cholangiocarcinoma via FXR. J Hematol OncolJ Hematol Oncol 4:41. https:\/\/doi.org\/10.1186\/1756-8722-4-41","journal-title":"J Hematol OncolJ Hematol Oncol"},{"key":"3321_CR10","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1124\/dmd.111.040758","volume":"40","author":"S Dawson","year":"2012","unstructured":"Dawson S, Stahl S, Paul N, Barber J, Kenna JG (2012) In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans. Drug Metab Dispos 40:130\u2013138. https:\/\/doi.org\/10.1124\/dmd.111.040758","journal-title":"Drug Metab Dispos"},{"key":"3321_CR11","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1517\/17425255.3.6.879","volume":"3","author":"IAM de de Graaf","year":"2007","unstructured":"de Graaf de IAM, Groothuis GMM, Olinga P (2007) Precision-cut tissue slices as a tool to predict metabolism of novel drugs. Expert Opin Drug Metab Toxicol 3:879\u2013898. https:\/\/doi.org\/10.1517\/17425255.3.6.879","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"3321_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1194\/jlr.RA119000243","volume":"24","author":"JF de Boer","year":"2019","unstructured":"de Boer JF, Verkade E, Mulder NL, de Vries HD, Huijkman NC, Koehorst M, Boer T, Wolters JC, Bloks VW, van de Sluis B, Kuipers F (2019) A human-like bile acid pool induced by deletion of Cyp2c70 modulates effects of farnesoid X receptor activation in mice. J Lipid Res 24:3. https:\/\/doi.org\/10.1194\/jlr.RA119000243","journal-title":"J Lipid Res"},{"key":"3321_CR13","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/nprot.2010.111","volume":"5","author":"IAM de Graaf","year":"2010","unstructured":"de Graaf IAM, Olinga P, de Jager MH, Merema MT, de Kanter R, van de Kerkhof EG, Groothuis GMM (2010) Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies. Nat Protoc 5:1540\u20131551. https:\/\/doi.org\/10.1038\/nprot.2010.111","journal-title":"Nat Protoc"},{"key":"3321_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0378-4274(92)90156-e","volume":"61","author":"NM Delzenne","year":"1992","unstructured":"Delzenne NM, Calderon PB, Taper HS, Roberfroid MB (1992) Comparative hepatotoxicity of cholic acid, deoxycholic acid and lithocholic acid in the rat: in vivo and in vitro studies. Toxicol Lett 61:291\u2013304. https:\/\/doi.org\/10.1016\/0378-4274(92)90156-e","journal-title":"Toxicol Lett"},{"key":"3321_CR15","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/S0940-2993(00)80059-7","volume":"52","author":"C Drobner","year":"2000","unstructured":"Drobner C, Gl\u00f6ckner R, M\u00fcller D (2000) Optimal oxygen tension conditions for viability and functioning of precision-cut liver slices. Exp Toxicol Pathol off J Ges Toxikol Pathol 52:335\u2013338. https:\/\/doi.org\/10.1016\/S0940-2993(00)80059-7","journal-title":"Exp Toxicol Pathol off J Ges Toxikol Pathol"},{"key":"3321_CR16","doi-asserted-by":"publisher","first-page":"G1008","DOI":"10.1152\/ajpgi.00071.2004","volume":"287","author":"MGL Elferink","year":"2004","unstructured":"Elferink MGL, Olinga P, Draaisma AL, Merema MT, Faber KN, Slooff MJH, Meijer DKF, Groothuis GMM (2004) LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am J Physiol-Gastrointest Liver Physiol 287:G1008\u2013G1016. https:\/\/doi.org\/10.1152\/ajpgi.00071.2004","journal-title":"Am J Physiol-Gastrointest Liver Physiol"},{"key":"3321_CR17","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1194\/jlr.D028803","volume":"53","author":"JC Garc\u00eda-Ca\u00f1averas","year":"2012","unstructured":"Garc\u00eda-Ca\u00f1averas JC, Donato MT, Castell JV, Lahoz A (2012) Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method. J Lipid Res 53:2231\u20132241. https:\/\/doi.org\/10.1194\/jlr.D028803","journal-title":"J Lipid Res"},{"key":"3321_CR18","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1124\/dmd.113.054189","volume":"42","author":"B Garzel","year":"2014","unstructured":"Garzel B, Yang H, Zhang L, Huang S-M, Polli JE, Wang H (2014) The role of bile salt export pump gene repression in drug-induced cholestatic liver toxicity. Drug Metab Dispos 42:318\u2013322. https:\/\/doi.org\/10.1124\/dmd.113.054189","journal-title":"Drug Metab Dispos"},{"key":"3321_CR19","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0378-1119(99)00460-6","volume":"241","author":"RM Green","year":"2000","unstructured":"Green RM, Hoda F, Ward KL (2000) Molecular cloning and characterization of the murine bile salt export pump. Gene 241:117\u2013123. https:\/\/doi.org\/10.1016\/S0378-1119(99)00460-6","journal-title":"Gene"},{"key":"3321_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1194\/jlr.C120000621","volume":"61","author":"GL Guo","year":"2020","unstructured":"Guo GL, Chiang JYL (2020) Is CYP2C70 the key to new mouse models to understand bile acids in humans?1. J Lipid Res 61:269\u2013271. https:\/\/doi.org\/10.1194\/jlr.C120000621","journal-title":"J Lipid Res"},{"key":"3321_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jhep.2012.08.002","volume":"58","author":"E Halilbasic","year":"2013","unstructured":"Halilbasic E, Claudel T, Trauner M (2013) Bile acid transporters and regulatory nuclear receptors in the liver and beyond. J Hepatol 58:155\u2013168. https:\/\/doi.org\/10.1016\/j.jhep.2012.08.002","journal-title":"J Hepatol"},{"key":"3321_CR22","doi-asserted-by":"publisher","first-page":"35434","DOI":"10.1038\/srep35434","volume":"6","author":"DFG Hendriks","year":"2016","unstructured":"Hendriks DFG, Fredriksson Puigvert L, Messner S, Mortiz W, Ingelman-Sundberg M (2016) Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability. Sci Rep 6:35434. https:\/\/doi.org\/10.1038\/srep35434","journal-title":"Sci Rep"},{"key":"3321_CR23","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S0022-2275(20)38331-0","volume":"30","author":"DM Heuman","year":"1989","unstructured":"Heuman DM (1989) Quantitative estimation of the hydrophilic-hydrophobic balance of mixed bile salt solutions. J Lipid Res 30:719\u2013730","journal-title":"J Lipid Res"},{"key":"3321_CR24","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1053\/j.gastro.2010.09.004","volume":"139","author":"GM Hirschfield","year":"2010","unstructured":"Hirschfield GM, Heathcote EJ, Gershwin ME (2010) Pathogenesis of cholestatic liver disease and therapeutic approaches. Gastroenterology 139:1481\u20131496. https:\/\/doi.org\/10.1053\/j.gastro.2010.09.004","journal-title":"Gastroenterology"},{"key":"3321_CR25","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1194\/jlr.RA119000395","volume":"61","author":"A Honda","year":"2020","unstructured":"Honda A, Miyazaki T, Iwamoto J, Hirayama T, Morishita Y, Monma T, Ueda H, Mizuno S, Sugiyama F, Takahashi S, Ikegami T (2020) Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition. J Lipid Res 61:54\u201369. https:\/\/doi.org\/10.1194\/jlr.RA119000395","journal-title":"J Lipid Res"},{"key":"3321_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2133\/dmpk.18.16","volume":"18","author":"M Horikawa","year":"2003","unstructured":"Horikawa M, Kato Y, Tyson CA, Sugiyama Y (2003) Potential cholestatic activity of various therapeutic agents assessed by bile canalicular membrane vesicles isolated from rats and humans. Drug Metab Pharmacokinet 18:16\u201322. https:\/\/doi.org\/10.2133\/dmpk.18.16","journal-title":"Drug Metab Pharmacokinet"},{"key":"3321_CR27","first-page":"351","volume-title":"Experimental cholestasis research","author":"REH Karsten","year":"2019","unstructured":"Karsten REH, Oosterhuis D, van Wijk LA, Olinga P (2019) Ex vivo model in cholestasis research. Experimental cholestasis research. Humana Press, New York, pp 351\u2013362"},{"key":"3321_CR28","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202001989RR","volume":"35","author":"AM Kemas","year":"2021","unstructured":"Kemas AM, Youhanna S, Zandi Shafagh R, Lauschke VM (2021) Insulin-dependent glucose consumption dynamics in 3D primary human liver cultures measured by a sensitive and specific glucose sensor with nanoliter input volume. FASEB J 35:e21305. https:\/\/doi.org\/10.1096\/fj.202001989RR","journal-title":"FASEB J"},{"key":"3321_CR29","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1124\/dmd.108.024778","volume":"37","author":"E Kis","year":"2009","unstructured":"Kis E, Ioja E, Nagy T, Szente L, Her\u00e9di-Szab\u00f3 K, Krajcsi P (2009) Effect of membrane cholesterol on BSEP\/Bsep activity: species specificity studies for substrates and inhibitors. Drug Metab Dispos 37:1878\u20131886. https:\/\/doi.org\/10.1124\/dmd.108.024778","journal-title":"Drug Metab Dispos"},{"key":"3321_CR30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/clpt.2012.79","volume":"92","author":"K K\u00f6ck","year":"2012","unstructured":"K\u00f6ck K, Brouwer KLR (2012) A perspective on efflux transport proteins in the liver. Clin Pharmacol Ther 92:599\u2013612. https:\/\/doi.org\/10.1038\/clpt.2012.79","journal-title":"Clin Pharmacol Ther"},{"key":"3321_CR31","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1124\/dmd.113.054304","volume":"42","author":"K K\u00f6ck","year":"2014","unstructured":"K\u00f6ck K, Ferslew BC, Netterberg I, Yang K, Urban TJ, Swaan PW, Stewart PW, Brouwer KLR (2014) Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4. Drug Metab Dispos 42:665\u2013674. https:\/\/doi.org\/10.1124\/dmd.113.054304","journal-title":"Drug Metab Dispos"},{"key":"3321_CR32","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1080\/00498250802040584","volume":"38","author":"A Kosters","year":"2008","unstructured":"Kosters A, Karpen SJ (2008) Bile acid transporters in health and disease. Xenobiotica Fate Foreign. Compd Biol Syst 38:1043\u20131071. https:\/\/doi.org\/10.1080\/00498250802040584","journal-title":"Compd Biol Syst"},{"key":"3321_CR33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1023\/a:1015379815897","volume":"18","author":"H Martin","year":"2002","unstructured":"Martin H, Sarsat JP, Lerche-Langrand C, Housset C, Balladur P, Toutain H, Albaladejo V (2002) Morphological and biochemical integrity of human liver slices in long-term culture: effects of oxygen tension. Cell Biol Toxicol 18:73\u201385. https:\/\/doi.org\/10.1023\/a:1015379815897","journal-title":"Cell Biol Toxicol"},{"key":"3321_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.mce.2012.05.004","volume":"368","author":"T Matsubara","year":"2013","unstructured":"Matsubara T, Li F, Gonzalez FJ (2013) FXR signaling in the enterohepatic system. Mol Cell Endocrinol 368:17\u201329. https:\/\/doi.org\/10.1016\/j.mce.2012.05.004","journal-title":"Mol Cell Endocrinol"},{"key":"3321_CR35","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1093\/toxsci\/kfq269","volume":"118","author":"RE Morgan","year":"2010","unstructured":"Morgan RE, Trauner M, van Staden CJ, Lee PH, Ramachandran B, Eschenberg M, Afshari CA, Qualls CW, Lightfoot-Dunn R, Hamadeh HK (2010) Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicol Sci off J Soc Toxicol 118:485\u2013500. https:\/\/doi.org\/10.1093\/toxsci\/kfq269","journal-title":"Toxicol Sci off J Soc Toxicol"},{"key":"3321_CR36","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/toxsci\/kft176","volume":"136","author":"RE Morgan","year":"2013","unstructured":"Morgan RE, van Staden CJ, Chen Y, Kalyanaraman N, Kalanzi J, Dunn RT, Afshari CA, Hamadeh HK (2013) A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. Toxicol Sci off J Soc Toxicol 136:216\u2013241. https:\/\/doi.org\/10.1093\/toxsci\/kft176","journal-title":"Toxicol Sci off J Soc Toxicol"},{"key":"3321_CR37","doi-asserted-by":"publisher","first-page":"G391","DOI":"10.1152\/ajpgi.00496.2006","volume":"293","author":"AD Mottino","year":"2007","unstructured":"Mottino AD, Hoffman T, Crocenzi FA, S\u00e1nchez Pozzi EJ, Roma MG, Vore M (2007) Disruption of function and localization of tight junctional structures and Mrp2 in sustained estradiol-17\u03b2-d-glucuronide-induced cholestasis. Am J Physiol-Gastrointest Liver Physiol 293:G391\u2013G402. https:\/\/doi.org\/10.1152\/ajpgi.00496.2006","journal-title":"Am J Physiol-Gastrointest Liver Physiol"},{"key":"3321_CR38","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1053\/jhep.2001.24171","volume":"33","author":"J Noe","year":"2001","unstructured":"Noe J, Hagenbuch B, Meier PJ, St-Pierre MV (2001) Characterization of the mouse bile salt export pump overexpressed in the baculovirus system. Hepatol Baltim Md 33:1223\u20131231. https:\/\/doi.org\/10.1053\/jhep.2001.24171","journal-title":"Hepatol Baltim Md"},{"key":"3321_CR39","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1016\/j.xphs.2017.04.050","volume":"106","author":"E Ogimura","year":"2017","unstructured":"Ogimura E, Tokizono M, Sekine S, Nakagawa T, Bando K, Ito K (2017) Metabolic activation of cholestatic drug-induced bile acid-dependent toxicity in human sandwich-cultured hepatocytes. J Pharm Sci 106:2509\u20132514. https:\/\/doi.org\/10.1016\/j.xphs.2017.04.050","journal-title":"J Pharm Sci"},{"key":"3321_CR40","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/hep.24229","volume":"53","author":"MS Padda","year":"2011","unstructured":"Padda MS, Sanchez M, Akhtar AJ, Boyer JL (2011) Drug induced cholestasis. Hepatol Baltim Md 53:1377\u20131387. https:\/\/doi.org\/10.1002\/hep.24229","journal-title":"Hepatol Baltim Md"},{"key":"3321_CR41","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1124\/dmd.113.052415","volume":"41","author":"C Parmentier","year":"2013","unstructured":"Parmentier C, Truisi GL, Moenks K, Stanzel S, Lukas A, Kopp-Schneider A, Alexandre E, Hewitt PG, Mueller SO, Richert L (2013) Transcriptomic hepatotoxicity signature of chlorpromazine after short- and long-term exposure in primary human sandwich cultures. Drug Metab Dispos Biol Fate Chem 41:1835\u20131842. https:\/\/doi.org\/10.1124\/dmd.113.052415","journal-title":"Drug Metab Dispos Biol Fate Chem"},{"key":"3321_CR42","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.toxlet.2018.06.1069","volume":"295","author":"C Parmentier","year":"2018","unstructured":"Parmentier C, Hendriks DFG, Heyd B, Bachellier P, Ingelman-Sundberg M, Richert L (2018) Inter-individual differences in the susceptibility of primary human hepatocytes towards drug-induced cholestasis are compound and time dependent. Toxicol Lett 295:187\u2013194. https:\/\/doi.org\/10.1016\/j.toxlet.2018.06.1069","journal-title":"Toxicol Lett"},{"issue":"67\u201381","key":"3321_CR43","doi-asserted-by":"publisher","first-page":"vi","DOI":"10.1016\/S1089-3261(03)00135-1","volume":"8","author":"G Paumgartner","year":"2004","unstructured":"Paumgartner G, Beuers U (2004) Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. Clin Liver Dis 8(67\u201381):vi. https:\/\/doi.org\/10.1016\/S1089-3261(03)00135-1","journal-title":"Clin Liver Dis"},{"key":"3321_CR44","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1021\/jm7015683","volume":"51","author":"JM Pedersen","year":"2008","unstructured":"Pedersen JM, Matsson P, Bergstr\u00f6m CAS, Norinder U, Hoogstraate J, Artursson P (2008) Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2). J Med Chem 51:3275\u20133287. https:\/\/doi.org\/10.1021\/jm7015683","journal-title":"J Med Chem"},{"key":"3321_CR45","unstructured":"Pfizer (2020) In: Saf. Data Sheet Glynase PresTab Glibenclamide. https:\/\/safetydatasheets.pfizer.com\/. Accessed 10 Nov 2021"},{"key":"3321_CR46","unstructured":"Pharmacists Association (2021) Informatorium Medicamentorum, Monograph Ciclosporine. R Dutch Pharm Assoc KNMP"},{"key":"3321_CR47","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1210\/me.2002-0120","volume":"17","author":"I Pineda Torra","year":"2003","unstructured":"Pineda Torra I, Claudel T, Duval C, Kosykh V, Fruchart J-C, Staels B (2003) Bile acids induce the expression of the human peroxisome proliferator-activated receptor \u03b1 gene via activation of the farnesoid X receptor. Mol Endocrinol 17:259\u2013272. https:\/\/doi.org\/10.1210\/me.2002-0120","journal-title":"Mol Endocrinol"},{"key":"3321_CR48","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/B978-0-323-34062-5.00008-X","volume-title":"Blumgart\u2019s surgery of the liver, biliary tract and pancreas, 2-volume set","author":"HA Pitt","year":"2017","unstructured":"Pitt HA, Nakeeb A (2017) Chapter 8\u2014bile secretion and pathophysiology of biliary tract obstruction. In: Jarnagin WR (ed) Blumgart\u2019s surgery of the liver, biliary tract and pancreas, 2-volume set, 6th edn. Elsevier, Philadelphia, pp 123-132.e1","edition":"6"},{"key":"3321_CR49","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1053\/jhep.2001.23433","volume":"33","author":"SJ Rippin","year":"2001","unstructured":"Rippin SJ, Hagenbuch B, Meier PJ, Stieger B (2001) Cholestatic expression pattern of sinusoidal and canalicular organic anion transport systems in primary cultured rat hepatocytes. Hepatology 33:776\u2013782. https:\/\/doi.org\/10.1053\/jhep.2001.23433","journal-title":"Hepatology"},{"key":"3321_CR50","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/toxsci\/71.2.276","volume":"71","author":"ID Rom\u00e1n","year":"2003","unstructured":"Rom\u00e1n ID, Fern\u00e1ndez-Moreno MD, Fueyo JA, Roma MG, Coleman R (2003) Cyclosporin A induced internalization of the bile salt export pump in isolated rat hepatocyte couplets. Toxicol Sci 71:276\u2013281. https:\/\/doi.org\/10.1093\/toxsci\/71.2.276","journal-title":"Toxicol Sci"},{"key":"3321_CR51","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ejpb.2018.11.005","volume":"133","author":"MJR Ruigrok","year":"2018","unstructured":"Ruigrok MJR, Xian J-L, Frijlink HW, Melgert BN, Hinrichs WLJ, Olinga P (2018) siRNA-mediated protein knockdown in precision-cut lung slices. Eur J Pharm Biopharm 133:339\u2013348. https:\/\/doi.org\/10.1016\/j.ejpb.2018.11.005","journal-title":"Eur J Pharm Biopharm"},{"key":"3321_CR52","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C T method. Nat Protoc 3:1101\u20131108. https:\/\/doi.org\/10.1038\/nprot.2008.73","journal-title":"Nat Protoc"},{"key":"3321_CR53","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/toxsci\/kfv155","volume":"147","author":"A Sharanek","year":"2015","unstructured":"Sharanek A, Burban A, Humbert L, Bachour-El Azzi P, Felix-Gomes N, Rainteau D, Guillouzo A (2015) Cellular accumulation and toxic effects of bile acids in cyclosporine a-treated HepaRG hepatocytes. Toxicol Sci 147:573\u2013587. https:\/\/doi.org\/10.1093\/toxsci\/kfv155","journal-title":"Toxicol Sci"},{"key":"3321_CR54","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1053\/j.gastro.2020.10.002","volume":"160","author":"T Shinozawa","year":"2021","unstructured":"Shinozawa T, Kimura M, Cai Y, Saiki N, Yoneyama Y, Ouchi R, Koike H, Maezawa M, Zhang R-R, Dunn A, Ferguson A, Togo S, Lewis K, Thompson WL, Asai A, Takebe T (2021) High-fidelity drug-induced liver injury screen using human pluripotent stem cell-derived organoids. Gastroenterology 160:831-846.e10. https:\/\/doi.org\/10.1053\/j.gastro.2020.10.002","journal-title":"Gastroenterology"},{"key":"3321_CR55","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1039\/c2tx20051a","volume":"2","author":"VY Soldatow","year":"2013","unstructured":"Soldatow VY, LeCluyse EL, Griffith LG, Rusyn I (2013) In vitro models for liver toxicity testing. Toxicol Res 2:23\u201339. https:\/\/doi.org\/10.1039\/c2tx20051a","journal-title":"Toxicol Res"},{"key":"3321_CR56","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/toxsci\/kfr177","volume":"123","author":"P Song","year":"2011","unstructured":"Song P, Zhang Y, Klaassen CD (2011) Dose-response of five bile acids on serum and liver bile Acid concentrations and hepatotoxicty in mice. Toxicol Sci off J Soc Toxicol 123:359\u2013367. https:\/\/doi.org\/10.1093\/toxsci\/kfr177","journal-title":"Toxicol Sci off J Soc Toxicol"},{"key":"3321_CR57","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.tiv.2015.10.008","volume":"30","author":"V Starokozhko","year":"2015","unstructured":"Starokozhko V, Abza GB, Maessen HC, Merema MT, Kuper F, Groothuis GMM (2015) Viability, function and morphological integrity of precision-cut liver slices during prolonged incubation: Effects of culture medium. Toxicol in Vitro 30:288\u2013299. https:\/\/doi.org\/10.1016\/j.tiv.2015.10.008","journal-title":"Toxicol in Vitro"},{"key":"3321_CR58","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1007\/s00204-017-1960-7","volume":"91","author":"V Starokozhko","year":"2017","unstructured":"Starokozhko V, Greupink R, van de Broek P, Soliman N, Ghimire S, de Graaf IAM, Groothuis GMM (2017a) Rat precision-cut liver slices predict drug-induced cholestatic injury. Arch Toxicol 91:3403\u20133413. https:\/\/doi.org\/10.1007\/s00204-017-1960-7","journal-title":"Arch Toxicol"},{"key":"3321_CR59","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00204-016-1865-x","volume":"91","author":"V Starokozhko","year":"2017","unstructured":"Starokozhko V, Vatakuti S, Schievink B, Merema MT, Asplund A, Synnergren J, Aspegren A, Groothuis GMM (2017b) Maintenance of drug metabolism and transport functions in human precision-cut liver slices during prolonged incubation for 5 days. Arch Toxicol 91:2079\u20132092. https:\/\/doi.org\/10.1007\/s00204-016-1865-x","journal-title":"Arch Toxicol"},{"key":"3321_CR60","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1080\/21553769.2013.879925","volume":"7","author":"M Stojan\u010devi\u0107","year":"2013","unstructured":"Stojan\u010devi\u0107 M, Pavlovi\u0107 N, Golo\u010dorbin-Kon S, Mikov M (2013) Application of bile acids in drug formulation and delivery. Front Life Sci 7:112\u2013122. https:\/\/doi.org\/10.1080\/21553769.2013.879925","journal-title":"Front Life Sci"},{"key":"3321_CR61","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/0168-8227(91)90060-Q","volume":"13","author":"M Suzuki","year":"1991","unstructured":"Suzuki M, Kojima H, Nakano T, Kashiwagi A, Hidaka H, Kosugi K, Shigeta Y, Harano Y (1991) In vitro stimulation of glucose utilization by insulin in primary cultures of rat hepatocytes. Diabetes Res Clin Pract 13:163\u2013172. https:\/\/doi.org\/10.1016\/0168-8227(91)90060-Q","journal-title":"Diabetes Res Clin Pract"},{"key":"3321_CR62","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1755-8794-6-39","volume":"6","author":"E Szalowska","year":"2013","unstructured":"Szalowska E, Stoopen G, Groot MJ, Hendriksen PJM, Peijnenburg AACM (2013) Treatment of mouse liver slices with cholestatic hepatotoxicants results in down-regulation of Fxr and its target genes. BMC Med Genom 6:39. https:\/\/doi.org\/10.1186\/1755-8794-6-39","journal-title":"BMC Med Genom"},{"key":"3321_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.mex.2020.101080","volume":"7","author":"P Van Brantegem","year":"2020","unstructured":"Van Brantegem P, Chatterjee S, De Bruyn T, Annaert P, Deferm N (2020) Drug-induced cholestasis assay in primary hepatocytes. MethodsX 7:101080. https:\/\/doi.org\/10.1016\/j.mex.2020.101080","journal-title":"MethodsX"},{"key":"3321_CR64","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.tiv.2017.07.024","volume":"44","author":"WFPM Van den Hof","year":"2017","unstructured":"Van den Hof WFPM, Coonen MLJ, van Herwijnen M, Brauers K, Jennen D, Olde Damink SWM, Schaap FG, Kleinjans JCS (2017) Validation of gene expression profiles from cholestatic hepatotoxicants in vitro against human in vivo cholestasis. Toxicol in Vitro 44:322\u2013329. https:\/\/doi.org\/10.1016\/j.tiv.2017.07.024","journal-title":"Toxicol in Vitro"},{"key":"3321_CR65","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1016\/s0024-3205(01)01031-1","volume":"68","author":"VP Vanhulle","year":"2001","unstructured":"Vanhulle VP, Martiat GA, Verbeeck RK, Horsmans Y, Calderon PB, Eeckhoudt SL, Taper HS, Delzenne N (2001) Cryopreservation of rat precision-cut liver slices by ultrarapid freezing: influence on phase I and II metabolism and on cell viability upon incubation for 24 hours. Life Sci 68:2391\u20132403. https:\/\/doi.org\/10.1016\/s0024-3205(01)01031-1","journal-title":"Life Sci"},{"key":"3321_CR66","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s00204-016-1778-8","volume":"91","author":"S Vatakuti","year":"2017","unstructured":"Vatakuti S, Olinga P, Pennings JLA, Groothuis GMM (2017) Validation of precision-cut liver slices to study drug-induced cholestasis: a transcriptomics approach. Arch Toxicol 91:1401\u20131412. https:\/\/doi.org\/10.1007\/s00204-016-1778-8","journal-title":"Arch Toxicol"},{"key":"3321_CR67","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/S0016-5085(03)01068-0","volume":"125","author":"M Wagner","year":"2003","unstructured":"Wagner M, Fickert P, Zollner G, Fuchsbichler A, Silbert D, Tsybrovskyy O, Zatloukal K, Guo GL, Schuetz JD, Gonzalez FJ, Marschall H-U, Denk H, Trauner M (2003) Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice. Gastroenterology 125:825\u2013838. https:\/\/doi.org\/10.1016\/S0016-5085(03)01068-0","journal-title":"Gastroenterology"},{"key":"3321_CR68","doi-asserted-by":"publisher","first-page":"F1000 Faculty R","DOI":"10.12688\/f1000research.14841.1","volume":"7","author":"R Weiskirchen","year":"2018","unstructured":"Weiskirchen R, Weiskirchen S, Tacke F (2018) Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts. F1000Research 7:F1000 Faculty Rev-921. https:\/\/doi.org\/10.12688\/f1000research.14841.1","journal-title":"F1000Research"},{"key":"3321_CR69","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.taap.2013.11.017","volume":"274","author":"IM Westra","year":"2014","unstructured":"Westra IM, Oosterhuis D, Groothuis GMM, Olinga P (2014) Precision-cut liver slices as a model for the early onset of liver fibrosis to test antifibrotic drugs. Toxicol Appl Pharmacol 274:328\u2013338. https:\/\/doi.org\/10.1016\/j.taap.2013.11.017","journal-title":"Toxicol Appl Pharmacol"},{"key":"3321_CR70","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.tiv.2016.05.012","volume":"35","author":"IM Westra","year":"2016","unstructured":"Westra IM, Mutsaers HAM, Luangmonkong T, Hadi M, Oosterhuis D, de Jong KP, Groothuis GMM, Olinga P (2016) Human precision-cut liver slices as a model to test antifibrotic drugs in the early onset of liver fibrosis. Toxicol in Vitro 35:77\u201385. https:\/\/doi.org\/10.1016\/j.tiv.2016.05.012","journal-title":"Toxicol in Vitro"},{"key":"3321_CR71","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1002\/jps.23584","volume":"102","author":"K Yang","year":"2013","unstructured":"Yang K, K\u00f6ck K, Sedykh A, Tropsha A, Brouwer KL (2013) An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters. J Pharm Sci 102:3037\u20133057. https:\/\/doi.org\/10.1002\/jps.23584","journal-title":"J Pharm Sci"},{"key":"3321_CR72","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.drudis.2018.09.007","volume":"24","author":"T Yang","year":"2019","unstructured":"Yang T, Khan GJ, Wu Z, Wang X, Zhang L, Jiang Z (2019) Bile acid homeostasis paradigm and its connotation with cholestatic liver diseases. Drug Discov Today 24:112\u2013128. https:\/\/doi.org\/10.1016\/j.drudis.2018.09.007","journal-title":"Drug Discov Today"},{"key":"3321_CR73","doi-asserted-by":"publisher","first-page":"31441","DOI":"10.1074\/jbc.M200474200","volume":"277","author":"J Yu","year":"2002","unstructured":"Yu J, Lo J-L, Huang L, Zhao A, Metzger E, Adams A, Meinke PT, Wright SD, Cui J (2002) Lithocholic acid decreases expression of bile salt export pump through farnesoid X receptor antagonist activity. J Biol Chem 277:31441\u201331447. https:\/\/doi.org\/10.1074\/jbc.M200474200","journal-title":"J Biol Chem"},{"key":"3321_CR74","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3389\/fphar.2017.00256","volume":"8","author":"L Yu","year":"2017","unstructured":"Yu L, Liu X, Yuan Z, Li X, Yang H, Yuan Z, Sun L, Zhang L, Jiang Z (2017) SRT1720 alleviates ANIT-induced cholestasis in a mouse model. Front Pharmacol 8:256. https:\/\/doi.org\/10.3389\/fphar.2017.00256","journal-title":"Front Pharmacol"},{"key":"3321_CR75","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cbi.2016.03.019","volume":"255","author":"J Zhang","year":"2016","unstructured":"Zhang J, He K, Cai L, Chen Y-C, Yang Y, Shi Q, Woolf TF, Ge W, Guo L, Borlak J, Tong W (2016) Inhibition of bile salt transport by drugs associated with liver injury in primary hepatocytes from human, monkey, dog, rat, and mouse. Chem Biol Interact 255:45\u201354. https:\/\/doi.org\/10.1016\/j.cbi.2016.03.019","journal-title":"Chem Biol Interact"},{"key":"3321_CR76","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1021\/mp060010s","volume":"3","author":"G Zollner","year":"2006","unstructured":"Zollner G, Marschall H-U, Wagner M, Trauner M (2006) Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol Pharm 3:231\u2013251. https:\/\/doi.org\/10.1021\/mp060010s","journal-title":"Mol Pharm"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-022-03321-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00204-022-03321-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-022-03321-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T13:20:54Z","timestamp":1658928054000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00204-022-03321-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,16]]},"references-count":76,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["3321"],"URL":"https:\/\/doi.org\/10.1007\/s00204-022-03321-2","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,16]]},"assertion":[{"value":"25 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}